Diane E. Heck, Ph.D.
Dr. Heck’s research interests are focused on understanding mechanisms of inflammation and toxicity mediating chemical-induced injury, wound healing and carcinogenesis. Her recent studies have included developing insights into the pro-inflammatory effects of light on biological systems and the roles of free radicals in skin, eye and lung inflammation; her current projects are largely focused on developing medical countermeasures, treatments and therapeutics to address the effects of chemical toxicants and agents of mass destruction on civilian populations.
Dr. Heck’s interests include analyzing and understanding the effects of environmental contaminants on sensitive populations, she has participated as an ad hoc member of numerous panels addressing these issues including the National Institutes of Environmental Health Sciences and US Environmental Protection Agency, Development of a preliminary research strategy relating to health and environmental aspects of exposure to dioxin and related compounds in Vietnam, and the NATO – Human Factors and Medicine Panel, HFM-14,9 “Defense Against the Effects of Chemical Hazards: Toxicology, Diagnosis, and Medical Countermeasures”. She serves as a team member of the NASA Technology Engineering and Aerospace Mission Support (TEAMS), International Space Station Air Quality Monitoring System Assessment team: Technology assessment for advanced chemical monitoring for life support. Dr. Heck also maintains an active interest in children’s environmental health and remains a member and advisor to the Children’s Environmental Health Center of the Hudson Valley.
Hong Duck Kim, Ph.D.
Dr. Kim’s research interest will serve as a proof of principle to demonstrate whether our novel immune gene therapy modality with good epitope is effective in treating an animal model of AD. Dr. Kim’s aspiration is to teach our future leaders (M.P.H. or M.D.) insightful approaches to observing environmental issues globally and locally by learning to dissect disease with evaluation and monitoring technology including molecular communication and interaction synergy with environmental risk factor links and how to aspire motivation and build-up academic strengths through our academic courses focused on OMICS (Genomics, Proteomics and Glycomics) format.
Michael P. Shakarjian, Ph.D.
Program Director, M.P.H.
Dr. Shakarjian’s research activities include investigating countermeasures against dermatological and neurological poisons. In particular, he is investigating the effects of a seizure-inducing rodenticide that has been responsible for thousands of accidental and intentional poisonings. With his collaborators, Libor Velisek, Jana Veliskova, and Patric Stanton, he is searching for the most effective treatments for the convulsant syndrome produced by this poison. His support for this project comes from the NIH CounterACT (Countermeasures Against Chemical Threats) program and the NYMC Intramural Research Support Program.
Prior to his academic career, Dr. Shakarjian spent 10 years in the pharmaceutical and small biotechnology industries where he was involved in several areas of small molecule and protein-based therapeutics R&D, including target identification and validation, assay development, candidate screening, and GLP/GCP bioanalytical studies.